Introduction {#s1}
============

The current study aimed to perform a quantitative analysis on the literature of lignans to unveil the major contributors in terms of institutions, countries/regions, and journals. By analyzing the publication and citation data, the major research themes present in the lignan literature were identified and further discussed.

Lignans are 1,4-diarylbutan compounds derived from the shikimic acid biosynthetic pathway ([@B37]; [@B28]). In the 1970s, it was still commonly believed that lignans were synthesized in plants only ([@B26]). It was only in the 1980s when scientists identified lignans produced by microbes living in humans and animals ([@B6]). Geographically, the intakes are greater in the European population relative to the Asian population ([@B10]). The main common dietary lignans are secoisolariciresinol, lariciresinol, matairesinol, pinoresinol, medioresinol, and syringaresinol ([@B16]); the range of components is very wide and efforts on isolation of new compounds are being carried out ([@B21]; [@B69]). Plant lignans are metabolized to enterodiol and enterolactone, called enterolignans or mammalian lignans ([@B36]).

The recent work of [@B16]) well summarized the occurrence of lignans in food groups and existing lignan databases at European level. As reported by [@B16]), the main sources of dietary lignans are oilseeds such as flax, soy, rapeseed, and sesame; whole-grain cereals such as wheat, oats, rye, and barley; legumes; various vegetables and fruits (particularly berries); beverages (i.e., coffee, tea, and wine); and, recently, lignans are also determined in dairy products, meat, and fish ([@B63]; [@B41]; [@B42]; [@B46]; [@B61]; [@B47]; [@B34]; [@B35]; [@B18]; [@B32]; [@B33]; [@B58]; [@B43]; [@B57]; [@B14]; [@B20]; [@B44]; [@B19]; [@B62]; [@B4]; [@B3]).

Within the bioactive compounds realm ([@B54]; [@B55]; [@B13]; [@B17]), the class of lignans is of interest for their potential biological activities, i.e., estrogenic and antiestrogenic, antioxidant, anti-inflammatory, metabolism-modulating, anti-proliferative, and anticancerogenic properties ([@B9]; [@B60]; [@B66]; [@B38]; [@B82]). Moreover, it is worth mentioning that the spectrum of biological activities attributed to lignans is being enlarged, i.e., related to newly discovered compounds belonged to this group ([@B80]; [@B23]; [@B59]; [@B27]; [@B7]; [@B81]).

Several studies showed that consumption of lignan-rich diets, which contain vegetables, fruits, and whole grain products, may protect against chronic diseases, particularly hormone-dependent cancer and cardiovascular diseases ([@B67]; [@B49]; [@B11]; [@B25]; [@B48]; [@B79]; [@B39]; [@B15]; [@B52]). Proper evaluation of adherence, efficacy, and communication aspects should be taken into account as well as the retrospective analysis of databases as per recent studies in the field ([@B30]; [@B56]; [@B24]; [@B40]).

The overview presented in the current study should be helpful to readers in better understanding the lignan research community, identifying potential research directions and collaboration partners, and conducting more in-depth literature searches of chemicals/chemical classes of interest.

Materials and Methods {#s2}
=====================

In July 2019, we queried the Web of Science (WoS) Core Collection online database, owned by Clarivate Analytics, to identify lignan publications with the following search string: TOPIC = ("lignan\*"). This search identified publications mentioning the word "lignan" or its derivatives in the title, abstract, or keywords. No additional filters were placed on the search.

Data Extraction {#s2_1}
---------------

Several aspects of each publication identified from the search were recorded, namely: (1) publication year; (2) institutions; (3) countries/regions of the institutions; (4) journal title; (5) WoS journal category; (6) type of publication; (7) language; and (8) number of total citations received. By using the "Export Records to File" function of WoS, full records and cited references of the identified publications were exported as "tab-delimited text files" to VOSviewer for additional processing.

The VOSviewer software (v.1.6.11, 2019) was used to analyze the titles and abstracts of publications, by breaking down the paragraphs into words and phrases, associating them with the citation data of the publications, and presenting the results in the form of a bubble map ([@B64]). Default parameters were used for the analyses and visualizations. The size of a bubble represents the frequency of appearance of a term (multiple appearances of a word counted once, single use of the same word in a paper equally weighted). Two bubbles are positioned more closely to each other if the terms co-appeared more often in the analyzed publications. The color represents the averaged citations per publication (CPP). To simplify the bubble map, we analyzed and visualized words that appeared in at least 1% (n = 108) of the publications.

Apart from analyzing the whole dataset, we additionally probed into the articles published by the most prolific journals to see how many of them were uncited. According to Bradford\'s law of scattering, the core journals for a body of literature are defined as the prolific journals that collectively published 1/3 of the papers ([@B65]). Using the current analyzed dataset, we tested if the core journals had their impact factor negatively correlated to the proportion of uncited papers, which was previously demonstrated in another field ([@B72]). Pearson\'s correlation test was performed using SPSS 25.0 (IBM, New York, USA). Test results were significant if p \< 0.05.

Results {#s3}
=======

The literature search resulted in 10,742 publications. The earliest publications on lignans indexed in WoS were published in 1970, which isolated new lignans at that time and identified their structures ([@B12]). Over 80% of the analyzed papers have been published since the year 2000, and nearly 50% since the year 2010. The numbers of original articles (*n* = 9,422) and reviews (*n* = 644) were in the ratio of 14.6:1. Reviews were more cited (CPP = 56.8) than original articles (CPP = 22.5). The majority of the publications were written in English (*n* = 10,483; 97.6%). Contributions came from 4,748 institutions located in 141 countries/regions and were published in 1,509 journals. The top five contributors with regard to WoS category, journal, institution, and country/region are listed in [**Table 1**](#T1){ref-type="table"}. It is worth mentioning that *Molecules* was the 6^th^ most productive journal, with 208 lignan publications (1.9%) and CPP of 11.9. Nineteen journals collectively published 3,607 lignan publications and were considered as core journals ([**Table 2**](#T2){ref-type="table"}). Their impact factor did not correlate with the proportion of uncited papers (r = -0.257, p = 0.289). Though University of Helsinki was among the top 5 most productive institutions, Finland was ranked 9^th^ in terms of countries/regions (n = 437, 4.1%). The 5 most productive countries were all from Asia, except the United States.

###### 

The top five contributors in terms of Web of Science category, journal, institution, and country/region of publications concerning lignans.

  Contributor                                                        Publication count (% of total)   Citation per manuscript
  ------------------------------------------------------------------ -------------------------------- -------------------------
  *Web of Science category*                                                                           
  Pharmacology pharmacy                                              2,522 (23.5%)                    20.5
  Chemistry medicinal                                                2,520 (23.5%)                    18.9
  Plant sciences                                                     2,050 (19.1%)                    22.9
  Biochemistry molecular biology                                     1,796 (16.7%)                    24.8
  Chemistry multidisciplinary                                        1,509 (14.0%)                    16.3
  *Journal*                                                                                           
  Phytochemistry                                                     587 (5.5%)                       31
  Journal of Natural Products                                        345 (3.2%)                       27.1
  Planta Medica                                                      332 (3.1%)                       18.9
  Chemical and Pharmaceutical Bulletin                               266 (2.5%)                       28.4
  Journal of Agricultural and Food Chemistry                         213 (2.0%)                       54.5
  *Organization*                                                                                      
  Chinese Academy of Sciences                                        473 (4.4%)                       13.8
  University of Helsinki                                             246 (2.3%)                       81.9
  Chinese Academy of Medical Sciences Peking Union Medical College   195 (1.8%)                       14.0
  Kunming Institute of Botany                                        193 (1.8%)                       12.9
  Universidade de Sao Paulo                                          186 (1.7%)                       18.1
  *Country/Territory*                                                                                 
  China                                                              2,482 (23.1%)                    13.0
  United States                                                      1,321 (12.3%)                    41.2
  Japan                                                              1,305 (12.1%)                    24.5
  South Korea                                                        691 (6.4%)                       15.5
  India                                                              638 (5.9%)                       16.5

###### 

Core journals publishing lignan papers.

  Journal                                       Impact factor   Proportion of uncited lignan papers (in %)
  --------------------------------------------- --------------- --------------------------------------------
  Phytochemistry                                2.905           1.5
  Journal of Natural Products                   4.257           1.4
  Planta Medica                                 2.746           17.8
  Chemical & Pharmaceutical Bulletin            1.405           0.8
  Journal of Agricultural and Food Chemistry    3.571           3.8
  Molecules                                     3.060           15.9
  Tetrahedron Letters                           2.259           1.1
  Tetrahedron                                   2.379           1.8
  Natural Product Research                      1.999           13.7
  Journal of Organic Chemistry                  4.745           3.4
  Fitoterapia                                   2.431           13.4
  Biochemical Systematics and Ecology           1.127           12.1
  Journal of Ethnopharmacology                  3.414           2.5
  Journal of Asian Natural Products Research    1.170           7.1
  Bioorganic & Medicinal Chemistry Letters      2.448           2.8
  Food Chemistry                                5.399           4.8
  Phytochemistry Letters                        1.338           15.8
  Bioscience, Biotechnology, and Biochemistry   1.297           3.2
  Archives of Pharmacal Research                2.458           5.4

There were 311 terms that appeared in at least 1% (*n* = 108) of the 10,742 lignan publications ([**Figure 1**](#f1){ref-type="fig"}). The highly cited publications usually mentioned phytoestrogen (4.3%, *n* = 463, CPP = 64.6), isoflavone (3.6%, n = 391, CPP = 64.9), or related terms such as daidzein (2.3%, n = 243, CPP = 84.1), enterodiol (2.6%, n = 280, CPP = 51.4), enterolactone (4.6%, n = 496, CPP = 48.0), equol (1.5%, n = 158, CPP = 82.3), genistein (2.4%, n = 260, CPP = 84.2), and isoflavonoid (1.2%, n = 134, CPP = 99.8). These terms were often mentioned together with cancer (6.1%, n = 655, CPP = 51.8), breast cancer (2.2%, n = 237, CPP = 51.8), or cardiovascular disease (1.5%, n = 157, CPP = 61.9). Some of the main common dietary lignans were frequently mentioned, such as lariciresinol (1.4%, n = 147; CPP = 27.3), matairesinol (2.5%, n = 264; CPP = 44.1), pinoresinol (3.4%, n = 368; CPP = 30.1), secoisolariciresinol (2.6%, n = 279; CPP = 36.9), syringaresinol (1.4%, n = 146; CPP = 23.1). The structures of these chemicals are shown in [**Figure 2**](#f2){ref-type="fig"}. The top 20 recurring terms are listed in [**Table 3**](#T3){ref-type="table"}.

![Bubble map visualizing words from titles and abstracts of the 10,742 lignan publications. VOSviewer software was used to evaluate the recurring terms. Only the 311 terms that appeared in at least 1% (n = 108) of the publications were analyzed and visualized. The size of a bubble represents the frequency of appearance of a term (multiple appearances within one publication were treated as one appearance). Two bubbles are positioned more closely to each other if the terms co-appeared more often. The color represents the averaged citations per publication.](fphar-11-00037-g001){#f1}

![Chemical structures of key single phytochemicals or representatives of chemical classes that were often discussed in the evaluated lignan publications. In parentheses are the cited compound classes (*italic*), number of publications (*n*), and citations per publication (CPP) for each chemical or representative chemical class.](fphar-11-00037-g002){#f2}

###### 

The top 20 recurring terms from titles and abstracts.

  Term            Appearance (% of 10,742 publications)
  --------------- ---------------------------------------
  Lignan          5,700 (53.1%)
  Compound        3,995 (37.2%)
  Study           3,120 (29.0%)
  Effect          2,878 (26.8%)
  Activity        2,843 (26.5%)
  Structure       2,443 (22.7%)
  Analysis        2,121 (19.7%)
  Acid            1,768 (16.5%)
  Cell            1,629 (15.2%)
  Level           1,367 (12.7%)
  Concentration   1,365 (12.7%)
  Synthesis       1,347 (12.5%)
  Treatment       1,217 (11.3%)
  Value           1,197 (11.1%)
  Group           1,186 (11.0%)
  Plant           1,144 (10.6%)
  Addition        1,085 (10.1%)
  Data            1,065 (9.9%)
  Derivative      974 (9.1%)
  Content         949 (8.8%)

The keywords listed by authors and WoS (KeyWords Plus) were collectively analyzed. There were 88 keywords that appeared in at least 1% (*n* = 108) of the lignan publications, and the 20 most common ones are listed in [**Table 4**](#T4){ref-type="table"}. The keywords suggested that antioxidation (4.3%) and apoptosis (3.2%) were two frequently investigated themes, and that *in vitro* (5.0%) studies were prevalent.

###### 

The top 20 recurring keywords.

  Keyword                Occurrence (% of 10,742 publications)
  ---------------------- ---------------------------------------
  Lignans                3,825 (35.6%)
  Lignan                 1,358 (12.6%)
  Constituents           1,217 (11.3%)
  Derivatives            536 (5.0%)
  Neolignans             536 (5.0%)
  In-vitro               535 (5.0%)
  Flavonoids             509 (4.7%)
  Phytoestrogens         488 (4.5%)
  Antioxidant activity   458 (4.3%)
  Identification         438 (4.1%)
  Cells                  435 (4.0%)
  Leaves                 433 (4.0%)
  Antioxidant            399 (3.7%)
  Glycosides             388 (3.6%)
  Flaxseed               383 (3.6%)
  Inhibition             366 (3.4%)
  Enterolactone          347 (3.2%)
  Apoptosis              345 (3.2%)
  Acid                   344 (3.2%)
  Expression             334 (3.1%)

To analyze the temporal changes in the keywords, we separately assessed lignan publications in three time periods: 1990s and before, 2000s, and 2010s. The top 20 recurring keywords for each of the three periods are listed in [**Table 5**](#T5){ref-type="table"}. Antioxidant activity rose to popularity since the 2000s. Apoptosis, cytotoxicity, and oxidative stress became popular in the 2010s.

###### 

The top 20 recurring keywords in each decade.

  ------------------------------------------------------------------------------------------------------------------------
  1990s and before   Occurrence (% of 2,144)   2000s                  Occurrence\    2010s                  Occurrence\
                                                                      (% of 3,312)                          (% of 5,295)
  ------------------ ------------------------- ---------------------- -------------- ---------------------- --------------
  Lignans            593 (27.7)                Lignans                1,304 (39.4)   Lignans                1,928 (36.4)

  Lignan             192 (9.0)                 Lignan                 467 (14.1)     Constituents           708 (13.4)

  Constituents       148 (6.9)                 Constituents           361 (10.9)     Lignan                 699 (13.2)

  Neolignans         108 (5.0)                 Phytoestrogens         254 (7.7)      In-vitro               366 (6.9)

  Phytoestrogens     96 (4.5)                  Neolignans             180 (5.4)      Flavonoids             324 (6.1)

  Genistein          86 (4.0)                  Derivatives            179 (5.4)      Antioxidant activity   313 (5.9)

  Breast-cancer      60 (2.8)                  Enterolactone          157 (4.7)      Antioxidant            307 (5.8)

  Derivatives        60 (2.8)                  Flaxseed               152 (4.6)      Cells                  298 (5.6)

  Identification     57 (2.7)                  In-vitro               143 (4.3)      Derivatives            297 (5.6)

  Cancer             50 (2.3)                  Antioxidant activity   140 (4.2)      Leaves                 295 (5.6)

  Women              48 (2.2)                  Flavonoids             138 (4.2)      Apoptosis              272 (5.1)

  Chemistry          47 (2.2)                  Phyto-estrogens        132 (4.0)      Identification         266 (5.0)

  Flavonoids         47 (2.2)                  Breast-cancer          127 (3.8)      Expression             253 (4.8)

  Bark               46 (2.1)                  Inhibition             119 (3.6)      Glycosides             252 (4.8)

  Acid               45 (2.1)                  Metabolism             119 (3.6)      Neolignans             248 (4.7)

  Inhibition         44 (2.1)                  Identification         115 (3.5)      Phenolic-compounds     210 (4.0)

  Podophyllotoxin    44 (2.1)                  Acid                   114 (3.4)      Oxidative stress       209 (3.9)

  Diet               42 (2.0)                  Mammalian lignans      114 (3.4)      Flaxseed               203 (3.8)

  Estrogens          42 (2.0)                  Cells                  113 (3.4)      Inhibition             203 (3.8)

  Route              42 (2.0)                  Podophyllotoxin        113 (3.4)      Cytotoxicity           194 (3.7)
  ------------------------------------------------------------------------------------------------------------------------

Discussion {#s4}
==========

The current literature analysis on lignan publications revealed the large publication shares from Asian countries, which were consistent with related bodies of literature such as antioxidants and curcumin ([@B75]; [@B77]). Examples of some highly cited original research papers recently published by Asian teams in the 2010s, without international collaborations, are discussed here. For instance, a Chinese paper reported results from sesame transcriptomes that provide useful information for understanding the relevant lignan biosynthesis molecular mechanism ([@B68]). Another Chinese team tested the effects of new lignans and neolignans on inhibiting nitric oxide production in mouse macrophages and against serum deprivation-induced PC12 cell damage ([@B70]). These papers received over 100 citations. Meanwhile, Korean teams published the anti-inflammatory effects of several lignans isolated from *Schiandra chinensis* ([@B45]), and the hepatoprotective effect of pinoresinol isolated from *Forsythiae Fructus* ([@B31]). These papers were cited over 50 times. In Japan, a randomized controlled trial was conducted, and results found that oral intake of flaxseed (*Linum usitatissimum* L.) lignan could lower blood cholesterol level and risk of hepatic diseases in hypercholesterolemic men ([@B22]). Another Japanese team described an efficient synthetic route to synthesize herbindoles as naturally occurring forms ([@B53]). In India, researchers extracted, separated, and characterized sesame oil lignan ([@B50]) and reported a phylogenetic analysis of *L. usitatissimum* L. ([@B8]). These Japanese and Indian papers had around 40 citations each. All these examples demonstrate the variety of the lignan research field, which ranged from basic sciences to human clinical trials.

Similar to the related research fields of berries, dietary natural products, and functional foods ([@B73]; [@B76]; [@B78]), the bubble map suggested that cancer and cardiovascular diseases were highly cited topics for lignan research. Readers can refer to comprehensive reviews on the relationship between phytoestrogens (such as lignans and isoflavonoids) and Western diseases (such as breast cancer and coronary heart disease) ([@B2]; [@B51]). Their modulatory effects on steroid biosynthetic enzymes, hormone concentrations, and cellular events seem to be beneficial against cancer development ([@B2]; [@B51]). In the early 1990s, a Finnish-Japanese collaboration probed into the low mortality in hormone-dependent cancer among the Japanese and found that they had high intake of soybean products rich in phytoestrogens, as demonstrated by a high concentration of isoflavonoids (and lignans to a lesser extent) excreted in their urine ([@B1]). In the year 1997, a case-control study published in *Lancet* reported that a high intake of phytoestrogens particularly lignan enterolactone and isoflavone equol could substantially reduce breast cancer risk in women ([@B29]). Later, another paper reviewed data on existing epidemiologic studies and suggested that lignans and flavonoids have beneficial effects on cardiovascular diseases and lung cancer, but not other cancers ([@B5]). The issues of low bioavailability might partly explain the differences in the results obtained between studies using cell/animal models and humans, particularly for the anti-cancer effects ([@B71]).

In addition, the bubble map can also relate to some of the potential biological activities of lignans, e.g., estrogenic and antiestrogenic, antioxidant, anti-inflammatory, and anticancerogenic properties ([@B9]; [@B60]; [@B66]; [@B38]; [@B82]), especially with antioxidant and anti-inflammatory activity being identified as frequently mentioned terms, whereas they were strong interests in phytoestrogen and cancer.

By limiting to "articles" (excluding other publication types such as reviews), a quick query of "clinical trial\*" within the analyzed body of literature returned with 50 hits only. After evaluation, we found that there were only 19 randomized clinical trials, which was equivalent to 0.2% of the 10,742 lignan publications. A follow-up search in PubMed database with a query of "lignan\*" and limited article type to "Clinical Trial" returned with 121 hits, which was equivalent to 1.1% of the analyzed publications. With such a small ratio of clinical trials in the lignan research literature, we believe that more clinical trials should be conducted to substantiate the beneficial effects and optimal dose of lignan intake on humans. In addition, researchers are currently experiencing common difficulties in estimating the dietary intakes of lignans (and also other non-nutritive substances) because they are not routinely included in the food composition tables, and there exists variability in contents reactive to soil quality, sun exposure, etc. All these complicate the works concerning the dose of lignan intake.

This study inherited some limitations, such as using indexed data based on a single database (WoS). Furthermore, the latest research trends, if any, might remain undetected due to a lack of time to accumulate publication and citation counts. Similar to previous literature analyses on curcumin and resveratrol ([@B74]; [@B75]), we did not analyze the authorship of the lignan publications, as there existed many Chinese authors with similar initials that caused inaccurate counting. Analyzing authorship by authors\' full names was also not practical, as many publication records listed author initials only. Moreover, the analysis cannot evaluate the scientific methods used to determine the research findings (e.g., distinguish between *in vivo* work used to determine mechanistic relationships at a molecular level, and disease associations elucidated from population research). For an analysis of over 10,000 publications, this requires additional automatic labeling of the documents (data tagging), which is currently very limited in the literature databases. For Web of Science, for example, there are only a few publication types, e.g., articles, reviews, editorials. Besides, lignan sub-types and method of action in metabolizers are not analyzed.

Overall, the current report identified the terms and themes in the lignan research literature, being important in terms of publication and citation data. Results revealed several recurring or highly cited themes, implying that the bibliometric analysis was able to quantitatively highlight the topics in the field deemed important by the field experts.

Conclusions {#s5}
===========

To summarize, a bibliometric analysis was conducted to evaluate publications on lignans. The current findings revealed that the United States and Asian countries, such as China, Japan, South Korea, and India, were the most productive countries. Some productive institutions were based outside these countries, such as the University of Helsinki in Finland. Many of the publications were focused on pharmacology (23.5%), chemistry (23.5%), and plant sciences (19.1%). Over 80% of the analyzed papers have been published since year 2000, and nearly 50% since year 2010. The highly cited publications usually mentioned specific terms such as phytoestrogen, isoflavone, daidzein, enterodiol, enterolactone, equol, genistein, isoflavonoid, cancer, breast cancer, or cardiovascular disease. Some frequently mentioned and discussed main common dietary lignans were lariciresinol, matairesinol, pinoresinol, secoisolariciresinol, and syringaresinol.
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